Cardio Device Makers Seek Clarity On Trials For Novel Combination Products
This article was originally published in The Gray Sheet
Executive Summary
Device makers at the recent Cardiovascular Research Technologies (CRT) meeting in Washington, D.C., heard detailed tips - if not formal guidance - from FDA on how to plan pre-approval trials for drug-coated balloons, bioabsorbable stents and other novel combination products